Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ANEXSIA

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Standard Dose
750MG;10MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ANEXSIA is listed in Drugs@FDA under application 040468 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE Form and strength TABLET;ORAL - 750MG;10MG Sponsor MALLINCKRODT Submission history Latest submission status date: 2011-06-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview ANEXSIA is listed in Drugs@FDA under application 040468 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE Form and strength TABLET;ORAL - 750MG;10MG Sponsor MALLINCKRODT Submission history Latest submission status date: 2011-06-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
ANEXSIA (ACETAMINOPHEN; HYDROCODONE BITARTRATE) | Drug Monograph | MedicHelpline